Rare inherited EGFR mutation linked to dramatically increased lung cancer risk

A uncommon inherited mutation successful the Epidermal Growth Factor Receptor (EGFR) cistron is associated with a 25-fold accrued hazard of lung cancer, according to a survey by investigators astatine Dana-Farber Cancer Institute and 23andMe Research Institute. The findings included de-identified, aggregated familial information from much than 3.3 cardinal 23andMe research-consented participants.